| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/29/2010 | US20100105701 Gyrase inhibitors and uses thereof |
| 04/29/2010 | US20100105700 Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors |
| 04/29/2010 | US20100105699 Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 04/29/2010 | US20100105698 Therapeutic Methods and Compounds |
| 04/29/2010 | US20100105697 Therapeutic agents |
| 04/29/2010 | US20100105696 IMIDAZOQUINOLINES AS DUAL LIPID KINASE AND mTOR INHIBITORS |
| 04/29/2010 | US20100105695 Method for enhancing insulin secretion |
| 04/29/2010 | US20100105694 Substituted pyrazinone derivatives for use as a medicine |
| 04/29/2010 | US20100105693 Modulators of Muscarinic Receptors |
| 04/29/2010 | US20100105692 Dipterinyl Calcium Pentahydrate (DCP) and Therapeutic Methods Based Thereon |
| 04/29/2010 | US20100105691 Metformin folate and preparation of the same |
| 04/29/2010 | US20100105690 Lisofylline analogs and methods for use |
| 04/29/2010 | US20100105689 Novel 1,4- and 1,5-diarylsubstituted 1,2,3-triazoles useful as potassium channel modulators |
| 04/29/2010 | US20100105688 Pharmaceutical compositions comprising 3,5-diamino-6-(2,3-dichlophenyl)-1,2,4-triazine or r(-)-2,4-diamino-5-(2,3-dichlorophenyl)-6-fluoromethyl pyrimidine and an nk1 |
| 04/29/2010 | US20100105687 Methods for treating cognitive disorders using 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds |
| 04/29/2010 | US20100105686 Phenylsulfamoyl benzamide derivatives as bradykinin antagonists |
| 04/29/2010 | US20100105685 S-Nitrosothiol Compounds and Related Derivatives |
| 04/29/2010 | US20100105684 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments |
| 04/29/2010 | US20100105683 Compounds useful for inhibiting chk1 |
| 04/29/2010 | US20100105682 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 04/29/2010 | US20100105681 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 04/29/2010 | US20100105680 Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments |
| 04/29/2010 | US20100105679 5-pyridinone substituted indazoles |
| 04/29/2010 | US20100105678 Novel anxiolytic compounds |
| 04/29/2010 | US20100105677 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
| 04/29/2010 | US20100105676 Fused heterocyclic compounds useful as kinase modulators |
| 04/29/2010 | US20100105675 11 beta-hsd1 modulators |
| 04/29/2010 | US20100105674 Chemical Compounds |
| 04/29/2010 | US20100105673 Substituted aminofuranones and their use |
| 04/29/2010 | US20100105671 C7-fluoro substituted tetracycline compounds |
| 04/29/2010 | US20100105668 Quinazoline derivatives |
| 04/29/2010 | US20100105667 Quinoxaline- and Quinoline-Carboxamide Derivatives |
| 04/29/2010 | US20100105666 Triazabenzo (a)naphtho(2,1,8-cde) azulene compounds. |
| 04/29/2010 | US20100105665 Renin inhibitors |
| 04/29/2010 | US20100105664 Organic compounds |
| 04/29/2010 | US20100105663 2-(heteroaryl) alkyl indazole 6-phenyl and thienyl methyl amide as thrombin inhibitors |
| 04/29/2010 | US20100105662 Besifloxacin Ophthalmic Composition for the Treatment or Control of Infection |
| 04/29/2010 | US20100105661 Condensed pyridine compound |
| 04/29/2010 | US20100105660 Organic compounds75074 |
| 04/29/2010 | US20100105659 2-aminopyridine analogs as glucokinase activators |
| 04/29/2010 | US20100105658 Aza-bridged-ring compound |
| 04/29/2010 | US20100105657 Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease |
| 04/29/2010 | US20100105656 Triazolopyrazine derivatives |
| 04/29/2010 | US20100105655 Novel compounds 515 |
| 04/29/2010 | US20100105654 Substituted quinazolinone compounds |
| 04/29/2010 | US20100105653 Pyrrolopyrimidine compounds and their uses |
| 04/29/2010 | US20100105652 Purines as cysteine protease inhibitors |
| 04/29/2010 | US20100105651 Antagonists of sns sodium channels |
| 04/29/2010 | US20100105650 Substituted isoquinoline and isoquinolinone derivatives |
| 04/29/2010 | US20100105649 Veterinary compositions for treating mastitis |
| 04/29/2010 | US20100105648 Solid pharmaceutical composition comprising (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chroman |
| 04/29/2010 | US20100105646 Allopregnanolone in a method for enhancing neurological function (alzheimer disease) |
| 04/29/2010 | US20100105645 Inhibition of ppar gamma expression by specific osteogenic oxysterols |
| 04/29/2010 | US20100105644 Botanical composition for enhanced skin repair and uses thereof |
| 04/29/2010 | US20100105643 Ophthalmic composition |
| 04/29/2010 | US20100105642 Novel compounds 409 |
| 04/29/2010 | US20100105641 Oral Contraceptive Spray |
| 04/29/2010 | US20100105640 Aromatase Inhibitors for Emergency Contraception |
| 04/29/2010 | US20100105639 Mesalamine suppository |
| 04/29/2010 | US20100105638 Cosmetic compositions |
| 04/29/2010 | US20100105637 Drug-surfactant complexes for sustained release |
| 04/29/2010 | US20100105636 T-type calcium channel blocker |
| 04/29/2010 | US20100105635 Composition for prevention or treatment of disease associated with amyloidosis through inhibition of amyloid protein aggregation and promotion of amyloid protein degradation |
| 04/29/2010 | US20100105634 Use of glucosamine as a mental and physical stress recovery enhancer and a performance enhancer |
| 04/29/2010 | US20100105633 Process |
| 04/29/2010 | US20100105632 Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 04/29/2010 | US20100105631 Inositol Compounds and Uses of Same in the Treatment of Diseases Characterized by Abnormal Protein Folding or Aggregation or Amyloid Formation, Desposition, Accumulation or Persistence |
| 04/29/2010 | US20100105630 Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders |
| 04/29/2010 | US20100105629 N-Substituted Peptidomimetic Inhibitors of Dipeptidylpeptidase IV |
| 04/29/2010 | US20100105628 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 04/29/2010 | US20100105614 Ultra low dose doxepin and methods of using the same to treat sleep disorders |
| 04/29/2010 | US20100105613 Therapeutic agent for occlusive peripheral vascular disease, and use thereof |
| 04/29/2010 | US20100105611 Method of treating respiratory disorders |
| 04/29/2010 | US20100105610 Methods of Inhibiting Tumor Cell Aggressiveness Using the Microenvironment of Human Embryonic Stem Cells |
| 04/29/2010 | US20100105604 Allyloxy and alkyloxy benzoic acid delivery agents |
| 04/29/2010 | US20100104675 Method Of Treating Demyelinating Central Nervous System Diseases |
| 04/29/2010 | US20100104673 Methods and Compositions for Treatment of Skin Conditions |
| 04/29/2010 | US20100104670 Use of chitosans for the treatment of nail inflammatory diseases |
| 04/29/2010 | US20100104669 Method for preparing an aqueous solution containing triterpenic acid, aqueous solution containing triterpenic acid, and use thereof |
| 04/29/2010 | US20100104665 Methods and Apparatus for Treating Rhinitis |
| 04/29/2010 | US20100104664 Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods |
| 04/29/2010 | US20100104662 Composition and methods for modulating cell proliferation and cell death |
| 04/29/2010 | US20100104661 Discontinuous methods of treating cancer |
| 04/29/2010 | US20100104660 Composition and method for treating tumor |
| 04/29/2010 | US20100104659 Benzopyranopyrazoles |
| 04/29/2010 | US20100104655 Therapeutic Polymeric Nanoparticles Comprising Vinca Alkaloids and Methods of Making and Using Same |
| 04/29/2010 | US20100104654 Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof |
| 04/29/2010 | US20100104651 Pharmaceutical Compositions Containing Diacerein |
| 04/29/2010 | US20100104649 Lercanidipine Hydrochloride Polymorphs and an Improved Process for Preparation of 1,1,N-Trimethyl-N-(3,3-Diphenylpropyl)-2-Aminoethyl Acetoacetate |
| 04/29/2010 | US20100104644 Compositions and Methods for Treating or Preventing Ophthalmic Disease |
| 04/29/2010 | US20100104643 Pharmaceutical compositions |
| 04/29/2010 | US20100104642 Hydrophilic foam and pharmaceutical dosage form employing the same |
| 04/29/2010 | US20100104640 Pharmaceutical compositions comprising irbesartan |
| 04/29/2010 | US20100104639 Bupropion hydrobromide and therapeutic applications |
| 04/29/2010 | US20100104638 Extended release oral acetaminophen/tramadol dosage form |
| 04/29/2010 | US20100104637 Tablet formulations containing 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom |
| 04/29/2010 | US20100104636 Pharmaceutical Compound and Composition |
| 04/29/2010 | US20100104635 Process for preparing granules of hydrophilic vitamins |
| 04/29/2010 | US20100104634 Pharmaceutical compositions of entacapone |
| 04/29/2010 | US20100104633 antifungal formulations comprising terbinafine or a pharmaceutically acceptable salt thereof, a lipid, and a surfactant; uses thereof for the treatment of skin and nail fungal infections |